Invention Grant
- Patent Title: Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agent
-
Application No.: US15749485Application Date: 2016-07-26
-
Publication No.: US10675257B2Publication Date: 2020-06-09
- Inventor: Philippe Guedat , Pierre Miniou
- Applicant: InFlectis BioScience
- Applicant Address: FR Nantes
- Assignee: INFLECTIS BIOSCIENCE
- Current Assignee: INFLECTIS BIOSCIENCE
- Current Assignee Address: FR Nantes
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@7e52f0e0
- International Application: PCT/EP2016/067791 WO 20160726
- International Announcement: WO2017/021216 WO 20170209
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/155 ; A61K31/519 ; A61P35/00 ; A61K31/4188
Abstract:
The present invention relates to a composition for use in treating a glioma or ameliorating the effects of a glioma, particularly glioblastoma, wherein said composition comprises a first active agent selected from the group consisting of a compound of formula (I), or a pharmaceutically acceptable salt thereof, (I) and a second active agent, which is temozolomide, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.
Public/Granted literature
Information query
